302 studies found for:
"Anaplastic astrocytoma"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
|
||||
| 2 | Terminated |
Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
|
||||
| 3 | Recruiting |
Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma
|
||||
| 4 | Recruiting |
Super-Selective Intraarterial Cerebral Infusion of Cetuximab for the Treatment of Recurrent Glioblastoma Multiforme and Anaplastic Astrocytoma
|
||||
| 5 | Recruiting |
Trial Of Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (TEMODAR) For Treatment Of Newly Diagnosed Glioblastoma Multiforme And Anaplastic Astrocytoma
|
||||
| 6 | Recruiting |
Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma
|
||||
| 7 | Recruiting |
Phase I/II Trial of the Safety, Tolerability, and Anti-tumor Efficacy of AXL1717 (Picropodophyllin) in the Treatment of Recurrent Malignant Astrocytomas
|
||||
| 8 |
Completed
Has Results |
A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma
|
||||
| 9 | Recruiting |
Trial Of Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab (Bevacizumab) For Treatment Of Relapsed/Refractory Glioblastoma Multiforme And Anaplastic Astrocytoma.
|
||||
| 10 | Recruiting |
A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
|
||||
| 11 | Terminated |
The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas
|
||||
| 12 | Completed |
BNCT to Treat Glioma That Has Progressed Following Radiotherapy
|
||||
| 13 | Completed |
Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma
|
||||
| 14 | Completed |
Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
|
||||
| 15 | Recruiting |
Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)
|
||||
| 16 | Completed |
Radiotherapy for Malignant Astrocytomas in the Elderly
|
||||
| 17 | Completed |
Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly
|
||||
| 18 | Recruiting |
A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
|
||||
| 19 | Active, not recruiting |
Sorafenib in Newly Diagnosed High Grade Glioma
|
||||
| 20 | Not yet recruiting |
Dendritic Cell Vaccine For Malignant Glioma and Glioblastoma Multiforme in Adult and Pediatric Subjects
|
† Indicates status has not been verified in more than two years
